New survey findings reveal the importance of offering patients choice when it comes to improving clinical trial diversity, access, and engagement.
Patients want options, or choice, when it comes to clinical trial participation. New data from a recent Study Voices survey reveals the impact choice can have on participation. The findings empower clinical trial sponsors to shift from traditional clinical trial enrollment models to hybrid enrollment models.
DOWNLOAD NOW
Read More
Topics:
Most Viewed,
Study Voices,
Aaron Fleishman,
International Clinical Trials,
Surveys,
Hybrid Clinical Trials
The clinical trial landscape saw a lot of changes in 2021, from decentralized clinical trial adoption to a greater emphasis on diversity and inclusion. But what’s in store for 2022? We asked our industry experts to weigh in with their predictions.
Read More
Topics:
Most Viewed,
Aaron Fleishman,
Mike Johnson,
Danielle Frate,
Dena Raffa,
2022 Predictions,
Justin Jones,
Crystal Ball
Catch Up on Our Content for Clinical Trial Sponsors
Now is the perfect time to catch up on our most popular content of 2021!
Featuring insights from industry thought leaders, our content provides clinical trial sponsors with knowledge and guidance to help navigate today’s challenging clinical trial enrollment and engagement landscape.
Read More
Topics:
RSG Arrive,
Diversity,
Inclusion,
Decentralized Clinical Trials,
Lookbook,
Creative Portfolio
The One Thing Every Sponsor Needs to Start a Decentralized Clinical Trial Off Right
I recently sat down with Chief Innovation Officer Rob Laurens to discuss how BBK's Engagement Solution Center solves many of the challenges sponsors face when planning and initiating a decentralized clinical trial.
Read More
Topics:
Rob Laurens,
Engagement Solution Center,
Decentralized Clinical Trials,
Focus 5,
Decentralized Solutions
Earlier this week, Cellectar Biosciences, a late-stage clinical biopharmaceutical company focused on the discovery and development of targeted drugs for the treatment of cancer, announced its partnership with BBK to provide concierge services for patients participating in its clinical studies. The services are designed to improve patients' and their caregivers' access to high-quality care and innovative treatments for their cancer.
Read More
Topics:
Most Viewed,
Concierge Services,
Cellectar
Earlier this week, BBK's Senior Director of Patient Engagement Services Mike Johnson spoke with Outsourcing-Pharma to discuss the RSG® Arrive travel program and its recent milestone of 20,000 completed trips.
In this in-depth interview, Mike discusses what sets this program apart from others as he highlights the concierge specialists who are experienced in understanding all the ramifications of a request, as it relates not only to arranging a travel itinerary but also ensuring the itinerary supports patient health, safety, and compliance. In addition, Mike shares insight into the significance of the milestone for BBK as well as the industry at large. Click here to read the full article.
Read More
Topics:
Patient Engagement,
Patient Centricity,
Patient Travel,
Most Viewed,
RSG Arrive,
Mike Johnson,
Outsourcing-Pharma,
Engagement Solution Center,
Concierge Services
Getting Decentralized Right
What Matters to Patients
In Part 2 of our two-part interview with Phil Kelly, we delve further into the patient perspective on decentralized clinical trials. We ask Phil Kelly to share his thoughts on patient needs, tools, technologies, and the patient experience.
If you are conducting a decentralized clinical trial or planning for one, this is a must-see segment, with valuable insight to leverage for success.

Read More
Topics:
Patient,
Pharma15 Live!,
Most Viewed,
Patient Voice,
Patient Centric,
Decentralized Clinical Trials,
Phil Kelly
RSG® Arrive Reaches Milestone of 20,000 Completed Trips
Enrollment, Engagement, and Satisfaction Data Confirms That Extending Study Support Beyond the Care Setting Yields Positive Results
Launched in 2012, RSG® Arrive has made clinical trial participation possible for thousands of patients worldwide. Today, the program has reached a major milestone with the completion of 20,000 trips.
Read More
Topics:
RSG Arrive,
Rob Laurens,
Mike Johnson,
Engagement Solution Center,
Patient Centric,
Press Release
Getting Decentralized Right
What Matters to Patients
We know the industry is ready to embrace decentralized clinical trials. But what about patients? What do they think about decentralized clinical trials? What elements are important to them? And what should sponsors consider when designing such trials?
To dig deep, we spoke one-on-one with Phil Kelly, a bladder cancer patient and advocate. He shares his experience and insight in Part 1 of this two-part series on the patient perspective.

Read More
Topics:
Patient,
Pharma15 Live!,
Most Viewed,
Patient Voice,
Patient Centric,
Decentralized Clinical Trials,
Phil Kelly
Think You Know Us? Take Another Look!
View our 2021 Lookbook.
We leverage empathy and care as we get to the heart of the patient experience and what it means to be a study participant in today’s rapidly changing world.
Read More
Topics:
Patient Recruitment,
Patient Engagement,
Creative,
Lookbook,
Creative Portfolio